Fully Automated Biochemical Analyzer Research Report： the market size is projected to reach USD 4.07 billion by 2030

According to the new market research report “Fully Automated Biochemical Analyzer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”, published by QYResearch, the global Fully Automated Biochemical Analyzer market size is projected to reach USD 4.07 billion by 2030, at a CAGR of 2.6% during the forecast period.

• Global Fully Automated Biochemical Analyzer MarketSize(US$ Million), 2019-2030

Source: QYResearch, "Fully Automated Biochemical Analyzer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”

Fully automatic biochemistry analyzer (FABCA) is a high-performance micro-controller based Photometric biochemistry analyzer used to measure various blood biochemical parameters such as blood glucose, urea, protein, and bilirubin etc. that are associated with various disorders such as diabetes, kidney diseases, liver malfunctions and other metabolic derangements. The quantization of these parameters is helpful in diagnosing health disorder. In the proposed project work, it is planned to automate the filter selection, sample aspiration, auto-calibration and other related parameters to be controlled through micro-controller-based hardware and software system. It is proposed to automate the sample handling system to cope up with the large no. of blood sample at a time.

• Global Fully Automated Biochemical Analyzer Top17Players Ranking and Market Share (Ranking is based on the revenue of 2023, continually updated)

Source: QYResearch, "Fully Automated Biochemical Analyzer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”

According to QYResearch Top Players Research Center, the global key manufacturers of Fully Automated Biochemical Analyzer include Roche, Danaher, Siemens Healthcare, Abbott, Hitachi, Mindray Medical, Thermo Scientific, KHB, ELITech, Horiba Medical, etc. In 2023, the global top five players had a share approximately 79.0% in terms of revenue.

Market Drivers:

The increasing demand for automation in laboratory processes was a significant driver. Auto biochemistry analyzers offer high levels of automation, reducing manual handling of samples and improving efficiency in laboratories.

The global rise in chronic diseases, such as diabetes, cardiovascular diseases, and liver disorders, increased the demand for diagnostic testing. Auto biochemistry analyzers play a crucial role in diagnosing and monitoring these conditions.

Restraint:

In regions with limited healthcare infrastructure, especially in remote or underserved areas, access to advanced diagnostic equipment, including auto biochemistry analyzers, may be limited. This poses challenges for ensuring widespread availability of diagnostic services.

The auto biochemistry analyzer market is competitive, with several established players. Intense competition and market saturation may make it challenging for new entrants to gain a foothold or for existing companies to differentiate their products.

Opportunity:

Emerging economies are investing in healthcare infrastructure development to address the growing healthcare needs of their populations. This includes the establishment of new hospitals, clinics, and diagnostic laboratories, creating a demand for advanced diagnostic equipment such as fully automated biochemical analyzers.

Continuous advancements in technology, including improved detection methods and data analysis capabilities, drove the development of more sophisticated auto biochemistry analyzers. This, in turn, enhanced the accuracy and reliability of test results.

About The Authors

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

Contact Us:

If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

E-mail: global@qyresearch.com

Tel: 001-626-842-1666(US)  0086-133 1872 9947(CN)

EN: https://www.qyresearch.com

JP: https://www.qyresearch.co.jp